Role of transrectal ultrasound guided salvage cryosurgery for recurrent prostate carcinoma after radiotherapy

Prostate Cancer Prostatic Dis. 2005;8(3):235-42. doi: 10.1038/sj.pcan.4500811.

Abstract

Despite improvements in treatment of localized prostate cancer, local recurrence remains a significant problem. A total of 46 patients with proven local cancer recurrence following external beam radiotherapy entered a prospective clinical trial using ultrasound-guided cryosurgery to ablate the residual prostate gland. Persistent complications included one urethra-rectal fistula, incontinence (2), retention (3), and treatment induced erectile dysfunction (7). Using the PSA definitions for biochemical failure as PSA>or=0.3 ng/ml, the Kaplan-Meier plots showed the incidence of patients to be free of biochemical recurrence at 51 and 44% at 1 and 2 y, respectively. For a PSA>or=1.0, the values at 1 and 2 y were 72 and 58%.

Publication types

  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Brachytherapy
  • Contrast Media / pharmacology
  • Cryosurgery / methods*
  • Cryotherapy
  • Erectile Dysfunction
  • Follow-Up Studies
  • Gadolinium DTPA / pharmacology
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Models, Biological
  • Neoplasm Recurrence, Local
  • Prospective Studies
  • Prostate / diagnostic imaging
  • Prostate / metabolism
  • Prostate-Specific Antigen / biosynthesis
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / radiotherapy*
  • Prostatic Neoplasms / surgery*
  • Radiotherapy / methods*
  • Recurrence
  • Salvage Therapy
  • Time Factors
  • Ultrasonography

Substances

  • Contrast Media
  • Prostate-Specific Antigen
  • Gadolinium DTPA